{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:35:53Z","timestamp":1787884553995,"version":"build-2784847793"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Abnormal liver function tests (LFTs) are common in ambulatory heart failure (HF). The aim of this study was to characterize abnormal LFTs during index hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A post-hoc analysis was carried out of the placebo group of the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan) trial, which enrolled patients hospitalized for HF with an ejection fraction (EF) \u226440% and no history of primary significant liver disease or acute hepatic failure. LFTs (abbreviation, cut-offs for abnormal values) including serum albumin (ALB, &amp;lt;3.3 g\/dL), aspartate transaminase (AST, &amp;gt;34 IU\/L), alanine transaminase (ALT, &amp;gt;34 IU\/L), alkaline phosphatase (AP, &amp;gt;123 IU\/L),\u03b3-glutamyl transferase (GGT, &amp;gt;50 IU\/L), and total bilirubin (T Bili, &amp;gt;1.2 mg\/dL) were measured at baseline, discharge\/day 7, and post-discharge. Co-primary endpoints were all-cause mortality (ACM) and cardiovascular mortality or first HF hospitalization (CVM + HFH). Study participants had a mean age of 65.6 \u00b112.0 years, were mostly male, reported high prevalences of medical co-morbidities, and were well treated with evidence-based therapies. Baseline LFT abnormalities were common (ALB 17%, AST 21%, ALT 21%, AP 23%, GGT 62%, and T Bili 26%). Abnormal T Bili was the only marker to decrease substantially from baseline (26%) to discharge\/day 7 (19%). All LFTs, except AP, improved post-discharge. Lower baseline ALB and elevated T Bili were associated with higher rates of ACM, and in-hospital decreases in ALB and increases in T Bili were associated with higher rates of both ACM and CVM + HFH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LFT abnormalities are common during hospitalization for HF in patients with reduced EF and were persistent at discharge. Baseline and in-hospital changes in ALB and T Bili provide additional prognostic value.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjhf\/hfs007","type":"journal-article","created":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T09:26:02Z","timestamp":1329902762000},"page":"302-311","source":"Crossref","is-referenced-by-count":175,"title":["Clinical Course and Predictive Value of Liver Function Tests in Patients Hospitalized for Worsening Heart Failure with Reduced Ejection Fraction: An Analysis of the EVEREST Trial"],"prefix":"10.1093","volume":"14","author":[{"given":"Andrew P.","family":"Ambrosy","sequence":"first","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine , Stanford, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthiah","family":"Vaduganathan","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine , Chicago, IL, 60611 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Huffman","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine , Chicago, IL ,","place":["USA"]},{"name":"Department of Preventive Medicine, Northwestern University Feinberg School of Medicine , Chicago, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadiya","family":"Khan","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine , Chicago, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Kwasny","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Northwestern University Feinberg School of Medicine , Chicago, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela J.","family":"Fought","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Northwestern University Feinberg School of Medicine , Chicago, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo P.","family":"Maggioni","sequence":"additional","affiliation":[{"name":"Associazione Nazionale Medici Cardiologi Ospedalieri Research Center , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Swedberg","sequence":"additional","affiliation":[{"name":"Department of Emergency and Cardiovascular Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin A.","family":"Konstam","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Tufts Medical Center and Tufts University School of Medicine , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nancy University , Nancy ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai","family":"Gheorghiade","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine , Chicago, IL, 60611 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,2,18]]},"reference":[{"key":"2026011921185345700_ejhfhfs007-bib-0001","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cardfail.2009.08.002","article-title":"Abnormal liver function in relation to hemodynamic profile in heart failure patients","volume":"16","author":"van Deursen","year":"2010","journal-title":"J Card Fail"},{"key":"2026011921185345700_ejhfhfs007-bib-0002","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1253\/circj.72.364","article-title":"Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure","volume":"72","author":"Shinagawa","year":"2008","journal-title":"Circ J"},{"key":"2026011921185345700_ejhfhfs007-bib-0003","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/oxfordjournals.eurheartj.a060785","article-title":"The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure","volume":"16","author":"Batin","year":"1995","journal-title":"Eur Heart J"},{"key":"2026011921185345700_ejhfhfs007-bib-0004","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/eurjhf\/hfn031","article-title":"Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program","volume":"11","author":"Allen","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026011921185345700_ejhfhfs007-bib-0005","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/01.CIR.2.2.286","article-title":"Liver function tests in chronic congestive heart failure","volume":"2","author":"Felder","year":"1950","journal-title":"Circulation"},{"key":"2026011921185345700_ejhfhfs007-bib-0006","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1172\/JCI100272","article-title":"Liver function in congestive heart failure","volume":"8","author":"Jolliffe","year":"1930","journal-title":"J Clin Invest"},{"key":"2026011921185345700_ejhfhfs007-bib-0007","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(61)90093-6","article-title":"Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes","volume":"30","author":"Richman","year":"1961","journal-title":"Am J Med"},{"key":"2026011921185345700_ejhfhfs007-bib-0008","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/hrt.13.3.273","article-title":"The liver in heart failure; relation of anatomical, functional, and circulatory changes","volume":"13","author":"Sherlock","year":"1951","journal-title":"Br Heart J"},{"key":"2026011921185345700_ejhfhfs007-bib-0009","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/CIRCULATIONAHA.109.192064","article-title":"2009 focused update: ACCF\/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation","volume":"119","author":"Jessup","year":"2009","journal-title":"Circulation"},{"key":"2026011921185345700_ejhfhfs007-bib-0010","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)","volume":"29","author":"Dickstein","year":"2008","journal-title":"Eur Heart J"},{"key":"2026011921185345700_ejhfhfs007-bib-0011","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cardfail.2005.03.009","article-title":"Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)","volume":"11","author":"Gheorghiade","year":"2005","journal-title":"J Card Fail"},{"key":"2026011921185345700_ejhfhfs007-bib-0012","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"key":"2026011921185345700_ejhfhfs007-bib-0013","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"2026011921185345700_ejhfhfs007-bib-0014","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1253\/circj.CJ-09-0498","article-title":"A simple risk score to predict in-hospital death of elderly patients with acute decompensated heart failure\u2014hypoalbuminemia as an additional prognostic factor","volume":"73","author":"Kinugasa","year":"2009","journal-title":"Circ J"},{"key":"2026011921185345700_ejhfhfs007-bib-0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ijcard.2007.07.094","article-title":"Usefulness of serum albumin concentration for in-hospital risk stratification in frail, elderly patients with acute heart failure. Insights from a prospective, monocenter study","volume":"125","author":"Arques","year":"2008","journal-title":"Int J Cardiol"},{"key":"2026011921185345700_ejhfhfs007-bib-0016","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.ahj.2010.09.004","article-title":"Serum albumin and mortality in acutely decompensated heart failure","volume":"160","author":"Uthamalingam","year":"2010","journal-title":"Am Heart J"},{"key":"2026011921185345700_ejhfhfs007-bib-0017","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jacc.2008.04.028","article-title":"Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)","volume":"52","author":"Abraham","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026011921185345700_ejhfhfs007-bib-0018","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ahj.2008.04.030","article-title":"Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)","volume":"156","author":"O'Connor","year":"2008","journal-title":"Am Heart J"},{"key":"2026011921185345700_ejhfhfs007-bib-0019","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.jacc.2008.07.056","article-title":"Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program","volume":"52","author":"Blair","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026011921185345700_ejhfhfs007-bib-0020","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ahj.2010.02.023","article-title":"Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program","volume":"159","author":"O'Connor","year":"2010","journal-title":"Am Heart J"},{"key":"2026011921185345700_ejhfhfs007-bib-0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2003.11.009","article-title":"Inadequate nutritional intake for daily life activity of clinically stable patients with chronic heart failure","volume":"93","author":"Pasini","year":"2004","journal-title":"Am J Cardiol"},{"key":"2026011921185345700_ejhfhfs007-bib-0022","first-page":"232","article-title":"Malnutrition, muscle wasting and cachexia in chronic heart failure: the nutritional approach","volume":"4","author":"Pasini","year":"2003","journal-title":"Ital Heart J"},{"key":"2026011921185345700_ejhfhfs007-bib-0023","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1378\/chest.115.3.836","article-title":"Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation","volume":"115","author":"Anker","year":"1999","journal-title":"Chest"},{"key":"2026011921185345700_ejhfhfs007-bib-0024","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(96)07015-8","article-title":"Wasting as independent risk factor for mortality in chronic heart failure","volume":"349","author":"Anker","year":"1997","journal-title":"Lancet"},{"key":"2026011921185345700_ejhfhfs007-bib-0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.hco.0000221585.94490.09","article-title":"Prognosis and therapy approaches of cardiac cachexia","volume":"21","author":"Springer","year":"2006","journal-title":"Curr Opin Cardiol"},{"key":"2026011921185345700_ejhfhfs007-bib-0026","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0002-9343(03)00132-3","article-title":"Decompensated heart failure: symptoms, patterns of onset, and contributing factors","volume":"114","author":"Schiff","year":"2003","journal-title":"Am J Med"},{"key":"2026011921185345700_ejhfhfs007-bib-0027","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/eurjhf\/hfr088","article-title":"Hypoalbuminaemia and incident heart failure in older adults","volume":"13","author":"Filippatos","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026011921185345700_ejhfhfs007-bib-0028","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.amjcard.2007.07.067","article-title":"Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry)","volume":"101","author":"Young","year":"2008","journal-title":"Am J Cardiol"},{"key":"2026011921185345700_ejhfhfs007-bib-0029","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/eurjhf\/hfq019","article-title":"Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial","volume":"12","author":"Dunlay","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026011921185345700_ejhfhfs007-bib-0030","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1161\/CIRCULATIONAHA.110.982207","article-title":"Postdischarge assessment after a heart failure hospitalization: the next step forward","volume":"122","author":"Metra","year":"2010","journal-title":"Circulation"},{"key":"2026011921185345700_ejhfhfs007-bib-0031","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nrcardio.2010.102","article-title":"Heart failure: early follow-up after hospitalization for heart failure","volume":"7","author":"Gheorghiade","year":"2010","journal-title":"Nat Rev Cardiol"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1093%2Feurjhf%2Fhfs007","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/14\/3\/302\/66443039\/eurjhf_14_3_302.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/14\/3\/302\/66443039\/eurjhf_14_3_302.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:25:04Z","timestamp":1768875904000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/14\/3\/302\/8429006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,1]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,2,18]]},"published-print":{"date-parts":[[2012,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjhf\/hfs007","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,3]]},"published":{"date-parts":[[2012,3,1]]}}}